OSIMERTINIB vs OXAZEPAM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OSIMERTINIB vs OXAZEPAM: Safety Overview
| Metric | OSIMERTINIB | OXAZEPAM |
|---|---|---|
| Total FAERS Reports | 27,750 | 12,440 |
| Deaths Reported | 12,456 | 2,965 |
| Death Rate | 44.9% | 23.8% |
| Hospitalizations | 5,277 | 6,242 |
| Average Patient Age | 68.2 yrs | 57.3 yrs |
| % Female Patients | 66.0% | 58.3% |
| FDA Approval Date | Nov 13, 2015 | Approved Prior to Jan 1, 1982 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Aphena Pharma Solutions - Tennessee, LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |